Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Boston Hotel

Aug 14, 2017 7:30 AM - Aug 17, 2017 5:00 PM

39 Dalton Street, , Boston, MA 02119 , USA

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 26: Review of Prescription Drug/Biologics Advertising and Promotional Labeling

Session Chair(s)

Elliott  Berger, PhD, MS

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

  • Definitions
  • Statutory basis for promotional regulations
  • Required elements for advertisements and promotional labeling
  • Reminder advertisements/labeling
  • Direct-to-Consumer (DTC) advertising
  • Social media
  • Disease awareness/help seeking
  • Launch of promotional pieces
  • Postmarketing submission of advertising
  • Preapproval promotional and dissemination of off-label information
  • FDA enforcement actions
  • Summary of principles for advertising and promotion

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.